ATS 2020 Advance Program

Objectives At the conclusion of this session, the participant will be able to: • apply a consistent, effective strategy to ILD/IPF diagnosis; • understand the range of therapeutics available for ILD and how and when to prescribe them; • integrate a holistic and interdisciplinary approach to ILD patient care. This course will provide a practical approach to the diagnosis and management of patients with ILD. It will bring the most recent recommendations and guidelines into a usable strategy that will facilitate the care of patients with ILD. This will be accomplished through didactics, simulated MDD and panel discussion of difficult cases which will provide a range of learning methods to reach the largest number of learners. Chairing: M. Kreider, MD, MSCE, ATSF, Philadelphia, PA S.K. Danoff, MD, PhD, ATSF, Baltimore, MD 8:00 Introduction M. Kreider, MD, MSCE, ATSF, Philadelphia, PA 8:15 Putting New Guidelines into Practice: Distinguishing IPF from Non-IPF ILD A. Podolanczuk, MD, New York, NY 8:45 GGOs, Reticulations, Honeycombing: Using Radiologic Patterns in the Diagnosis of ILD S. Hobbs, MD, Lexington, KY 9:15 Is Tissue the Issue: When, Who, and How to Biopsy K.A.M. Johannson, MD, MPH, ATSF, Calgary, Canada 9:45 Telomeres, SNPs and Surfactants: What’s the Role of Genetic Testing in ILD? J. Kropski, MD, Nashville, TN 10:15 Break 10:30 Speed MDD: Pulling It All Together L.P. Hariri, BS, MD, PhD, Boston, MA S. Hobbs, MD, Lexington, KY E.M. Wilfong, MD, PhD, Nashville, TN A.O. Adegunsoye, MD, MS, Chicago, IL T. Luckhardt, MD, Birmingham, AL M. Kreider, MD, MSCE, ATSF, Philadelphia, PA 11:45 LUNCH 12:15 IPF Therapy: Which One, When, and Why? T.M. Maher, MD, MSc, PhD, London, United Kingdom 12:45 Therapies for CTD-ILD: Moving Beyond Steroids C. Johnson, MD, Philadelphia, PA 1:15 The Nuts and Bolts of Monitoring Patients with ILD S.K. Danoff, MD, PhD, ATSF, Baltimore, MD 1:45 Controversies in Therapy- NAC, PH, GERD, Stem Cells J. Oldham, MD, MS, Sacramento, CA 2:15 Break 2:30 Tough Cases T.M. Maher, MD, MSc, PhD, London, United Kingdom K.A.M. Johannson, MD, MPH, ATSF, Calgary, Canada A.O. Adegunsoye, MD, MS, Chicago, IL T. Luckhardt, MD, Birmingham, AL E.M. Wilfong, MD, PhD, Nashville, TN J. Oldham, MD, MS, Sacramento, CA M. Kreider, MD, MSCE, ATSF, Philadelphia, PA L.P. Hariri, BS, MD, PhD, Boston, MA CLINICAL • TRANSLATIONAL POSTGRADUATE COURSE PG6 COPD 2020: STATE OF THE ART Pre-registration and additional fees required. Continental breakfast and box lunch included. Attendance is limited. Member: $350 In-Training Member: $200 Non-Member: $425 In-Training Non-Member: $300 Assemblies on Clinical Problems; Allergy, Immunology and Inflammation; Pulmonary Rehabilitation; Respiratory Structure and Function 8:00 a.m. - 4:00 p.m. Target Audience Clinicians, nurses, other allied health staff, researchers, ATS 2020 • Philadelphia, PA 6 FRIDAY • MAY 15